Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H Brakenhoff

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Oncogenesis|June 19, 2019
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell deathAnne M van Harten, Marijke Buijze, Richard van der Mast, et al.
International Journal of Cancer|August 8, 2007
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimenSerge J Smeets, Albertus T Hesselink, Ernst-Jan M Speel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2013
Identification of lethal microRNAs specific for head and neck cancerMarlon Lindenbergh-van der Plas, Sanne R Martens-de Kemp, Michiel de Maaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell CarcinomasTieneke B M Schaaij-Visser, A Peggy Graveland, Sharon Gauci, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletionMichaela Wrage, Salla Ruosaari, Paul P Eijk, et al.
Oncotarget|December 13, 2017
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neckD Vicky de Boer, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Molecular Cancer Therapeutics|October 13, 2023
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with ChemoradiotherapyJantine E Bakema, Marijke Stigter-van Walsum, Jeffrey R Harris, et al.
The Lancet. Oncology|November 28, 2012
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinomaFrank K J Leusink, Robert J J van Es, Remco de Bree, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Oncogenesis|June 19, 2019
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell deathAnne M van Harten, Marijke Buijze, Richard van der Mast, et al.
International Journal of Cancer|August 8, 2007
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimenSerge J Smeets, Albertus T Hesselink, Ernst-Jan M Speel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2013
Identification of lethal microRNAs specific for head and neck cancerMarlon Lindenbergh-van der Plas, Sanne R Martens-de Kemp, Michiel de Maaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell CarcinomasTieneke B M Schaaij-Visser, A Peggy Graveland, Sharon Gauci, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletionMichaela Wrage, Salla Ruosaari, Paul P Eijk, et al.
Oncotarget|December 13, 2017
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neckD Vicky de Boer, Sanne R Martens-de Kemp, Marijke Buijze, et al.
Molecular Cancer Therapeutics|October 13, 2023
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with ChemoradiotherapyJantine E Bakema, Marijke Stigter-van Walsum, Jeffrey R Harris, et al.
The Lancet. Oncology|November 28, 2012
Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinomaFrank K J Leusink, Robert J J van Es, Remco de Bree, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Pageof 20